SS
RCEL icon

SBI Securities’s Avita Medical RCEL Stock Holding History

SBI Securities’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09K Sell
295
-8
-3% -$34 ﹤0.01% 2625
2025
Q4 		$1.04K Buy
303
+106
+54% +$423 ﹤0.01% 2631
2025
Q3 		$1.01K Sell
197
-48
-20% -$250 ﹤0.01% 2690
2025
Q2 		$1.3K Sell
245
-1
-0.4% -$7 ﹤0.01% 2565
2025
Q1 		$2K Sell
246
-22
-8% -$206 ﹤0.01% 2289
2024
Q4 		$3.43K Buy
+268
New +$3.16K ﹤0.01% 2071

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBI Securities's RCEL Position: Q1 2026 in Review

SBI Securities reduced its Avita Medical (RCEL) stake by 2.6% in Q1 2026, selling an estimated $34 and leaving 295 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #2625.

SBI Securities first reported a position in RCEL in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.43K in Q4 2024. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • SBI Securities held 295 shares of Avita Medical worth $1.09K as of Q1 2026.
  • SBI Securities sold 8 Avita Medical shares in Q1 2026, an estimated $34.
  • Avita Medical made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2625 holding.
  • SBI Securities first reported a position in Avita Medical in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Avita Medical position peaked at $3.43K in Q4 2024.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.